Revlimid and Gingival erythema - from FDA reports

Gingival erythema is found among people who take Revlimid, especially for people who are female, 50-59 old also take medication Zometa, and have Hypercalcaemia. This study is created by eHealthMe based on reports of 140,106 people who have side effects when taking Revlimid from FDA, and is updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.

On Aug, 10, 2018

140,106 people reported to have side effects when taking Revlimid.
Among them, 43 people (0.03%) have Gingival erythema

Number of reports submitted per year:

Could Revlimid cause Gingival erythema?

Gender of people who have Gingival erythema when taking Revlimid *:

  • female: 69.77 %
  • male: 30.23 %

Age of people who have Gingival erythema when taking Revlimid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.7 %
  • 30-39: 0.0 %
  • 40-49: 5.41 %
  • 50-59: 81.08 %
  • 60+: 10.81 %

Top conditions involved for these people *:

  1. Hypercalcaemia (elevated calcium (ca+) level in the blood): 17 people, 39.53%
  2. Osteoporosis (bones weak and more likely to break): 15 people, 34.88%
  3. Anaemia (lack of blood): 5 people, 11.63%
  4. Metastases To Bone (cancer spreads to bone): 3 people, 6.98%
  5. Renal Cell Carcinoma (a kidney cancer): 1 person, 2.33%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 2.33%
  7. Herpes Simplex (herpes simplex is a common viral infection): 1 person, 2.33%
  8. Diabetes: 1 person, 2.33%
  9. Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 1 person, 2.33%
Check whether a drug or a condition causes Gingival erythema

Top co-used drugs for these people *:

  1. Zometa: 41 people, 95.35%
  2. Aredia: 39 people, 90.70%
  3. Aranesp: 26 people, 60.47%
  4. Decadron: 26 people, 60.47%
  5. Fosamax: 25 people, 58.14%
  6. Kytril: 21 people, 48.84%
  7. Velcade: 19 people, 44.19%
  8. Dexamethasone: 16 people, 37.21%
  9. Thalomid: 15 people, 34.88%
  10. Prempro: 15 people, 34.88%
Subscribe to monitor Gingival erythema in Revlimid

Top other side effects for these people *:

  1. Pain In Jaw: 35 people, 81.40%
  2. Chest Pain: 32 people, 74.42%
  3. Cough: 31 people, 72.09%
  4. Pain: 30 people, 69.77%
  5. Rashes (redness): 27 people, 62.79%
  6. Diarrhea: 27 people, 62.79%
  7. Osteonecrosis Of Jaw (death of bone of jaw): 25 people, 58.14%
  8. Chills (felling of cold): 24 people, 55.81%
  9. Fever: 24 people, 55.81%
  10. Toothaches (tooth pain): 24 people, 55.81%
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Revlimid or have questions?

Volunteer or get paid to help people with your care experience

Related studies


Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. (latest outcomes from Revlimid 140,338 users)

Gingival erythema

Gingival erythema (redness of gums) has been reported by people with metastases to bone, osteoporosis, breast cancer, multiple myeloma, pain (latest reports from 801 Gingival erythema patients).

Drugs that are associated with Gingival erythema
Gingival erythema (498 drugs)
Could your condition cause Gingival erythema
Gingival erythema (214 conditions)
Revlimid side effects
Browse all side effects of Revlimid
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Revlimid and have Gingival erythema

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Revlimid, Gingival erythema

Recent updates

General studies

You could also:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.